With the only U.S. patent for drug diversion, Medacist has a proven track record of delivering actionable solutions to over 3 million healthcare providers across 2,000+ facilities nationwide. The company’s unique combination of in-depth healthcare industry knowledge, new technology solutions, best-in-class customer service and attention to detail has established it as the premier resource in drug diversion analytics. Medacist’s Genesis™ analytics platform utilizes a proprietary knowledge base of 24 years of exclusive ADS and EMR data and leverages machine learning algorithms that identify diversion patterns, learned and confirmed by actual diversion events and enriched by other data sources. Their latest offering, RxAuditor Investigate™, is powered by the Genesis platform and helps target risk, decrease false positives, and eliminate the time-consuming tasks associated with the diversion auditing process with the primary goal of ensuring patient safety.
CONTACT INFORMATION:
Medacist Solutions Group
1492 Highland Avenue
Cheshire, CT 06410
TOLL-FREE: 866-633-5393
FAX: 203-272-8794
sales@medacist.com
info@medacist.com
www.medacist.com
